Evidence map›Paper›PMID 24733459›Full record

ArticleAntimicrobial agents and chemotherapy2014

Very-high-dose caspofungin combined with voriconazole to treat central nervous system aspergillosis: substantial penetration of caspofungin into cerebrospinal fluid.

François Réminiac, Romain Sonneville, Laurent Massias, Christian Chochillon, Michel Wolff

Open access · bronzeAbstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Chronic Meningitis.Continuum (Minneapolis, Minn.) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

François RéminiacAssistance Publique Hôpitaux de Paris AP-HP, Hôpital Bichat-Claude-Bernard, Service de Réanimation Médicale et Infectieuse, Université Paris Diderot, Sorbonne Paris Cité, Paris, France f.reminiac@yahoo.fr.
Romain SonnevilleAssistance Publique Hôpitaux de Paris AP-HP, Hôpital Bichat-Claude-Bernard, Service de Réanimation Médicale et Infectieuse, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Laurent MassiasAssistance Publique Hôpitaux de Paris AP-HP, Hôpital Bichat-Claude-Bernard, Laboratoire de Toxicologie-Pharmacocinétique, Service de Pharmacie, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Christian ChochillonAssistance Publique Hôpitaux de Paris AP-HP, Hôpital Bichat-Claude-Bernard, Service de Parasitologie, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Michel WolffAssistance Publique Hôpitaux de Paris AP-HP, Hôpital Bichat-Claude-Bernard, Service de Réanimation Médicale et Infectieuse, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
Sorbonne Paris Cité · FRDélégation Paris 7 · FRHôpital Bichat-Claude-Bernard · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAntifungal AgentsAspergillus fumigatusCaspofunginCentral Nervous System DiseasesDrug Therapy, CombinationEchinocandinsHumansLipopeptidesMaleNeuroaspergillosisVoriconazoleAntifungal AgentsCaspofunginEchinocandinsLipopeptidesVoriconazole

Identifiers

PMID24733459
PMCPMC4068458
OpenAlexW2144930666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.